MAWA
RMD icon

Moss Adams Wealth Advisors’s ResMed RMD Stock Holding History

Moss Adams Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$707K Sell
3,149
-11
-0.3% -$2.74K 0.05% 112
2025
Q4 		$761K Buy
3,160
+20
+0.6% +$5.12K 0.06% 100
2025
Q3 		$860K Buy
3,140
+33
+1% +$9.01K 0.07% 87
2025
Q2 		$802K Buy
3,107
+28
+0.9% +$6.68K 0.07% 95
2025
Q1 		$689K Buy
3,079
+23
+0.8% +$5.37K 0.07% 88
2024
Q4 		$699K Buy
3,056
+13
+0.4% +$3.13K 0.07% 81
2024
Q3 		$743K Buy
3,043
+60
+2% +$13.4K 0.08% 71
2024
Q2 		$571K Buy
2,983
+77
+3% +$15.6K 0.08% 76
2024
Q1 		$575K Buy
2,906
+176
+6% +$32.3K 0.09% 70
2023
Q4 		$470K Buy
2,730
+322
+13% +$49.5K 0.1% 57
2023
Q3 		$356K Sell
2,408
-279
-10% -$50.4K 0.12% 56
2023
Q2 		$587K Buy
2,687
+117
+5% +$26.1K 0.19% 41
2023
Q1 		$563K Sell
2,570
-230
-8% -$49.9K 0.19% 39
2022
Q4 		$583K Buy
+2,800
New +$615K 0.29% 51

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moss Adams Wealth Advisors's RMD Position: Q1 2026 in Review

Moss Adams Wealth Advisors reduced its ResMed (RMD) stake by 0.35% in Q1 2026, selling an estimated $2.74K and leaving 3,149 shares worth $707K. The position accounts for 0.05% of the portfolio, ranked #112.

Moss Adams Wealth Advisors first reported a position in RMD in Q4 2022 and has held it in 14 quarters since. The position peaked at $860K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Moss Adams Wealth Advisors held 3,149 shares of ResMed worth $707K as of Q1 2026.
  • Moss Adams Wealth Advisors sold 11 ResMed shares in Q1 2026, an estimated $2.74K.
  • ResMed made up 0.05% of Moss Adams Wealth Advisors's portfolio in Q1 2026, its #112 holding.
  • Moss Adams Wealth Advisors first reported a position in ResMed in Q4 2022 and has held it in 14 quarters since.
  • Moss Adams Wealth Advisors's ResMed position peaked at $860K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.